{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:56:36Z","timestamp":1769190996409,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,7]]},"DOI":"10.7759\/cureus.26635","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:42:53Z","timestamp":1657201373000},"source":"Crossref","is-referenced-by-count":5,"title":["A Rare Case of Empyema Complicated With Bronchopleural Fistula Secondary to Mucormycosis in a Young Immunocompromised Diabetic Patient With COVID-19"],"prefix":"10.7759","author":[{"given":"Ruby","family":"Risal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahmina","family":"Jahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pharlin","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal R","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneeta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: an opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi I","year":"2021","unstructured":"Mahalaxmi I, Jayaramayya K, Venkatesan D, et al.. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res. 2021, 201:111643. 10.1016\/j.envres.2021.111643","journal-title":"Environ Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world","volume":"186","author":"Muthu V","year":"2021","unstructured":"Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia. 2021, 186:739-54. 10.1007\/s11046-021-00584-8","journal-title":"Mycopathologia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.02.007","article-title":"Mucormycosis and COVID-19 pandemic: clinical and diagnostic approach","volume":"15","author":"Azhar A","year":"2022","unstructured":"Azhar A, Khan WH, Khan PA, Alhosaini K, Owais M, Ahmad A. Mucormycosis and COVID-19 pandemic: clinical and diagnostic approach. J Infect Public Health. 2022, 15:466-79. 10.1016\/j.jiph.2022.02.007","journal-title":"J Infect Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and mucormycosis superinfection: the perfect storm","volume":"49","author":"Al-Tawfiq JA","year":"2021","unstructured":"Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al.. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021, 49:833-53. 10.1007\/s15010-021-01670-1","journal-title":"Infection"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-021-01226-5","article-title":"Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India","volume":"74","author":"Singh K","year":"2022","unstructured":"Singh K, Kumar S, Shastri S, Sudershan A, Mansotra V. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India. Immunogenetics. 2022, 74:197-206. 10.1007\/s00251-021-01226-5","journal-title":"Immunogenetics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020, 6:10.3390\/jof6040265","journal-title":"J Fungi (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jof8010044","article-title":"Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes","volume":"8","author":"Janjua OS","year":"2021","unstructured":"Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, Zafar MS. Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes. J Fungi (Basel). 2021, 8:10.3390\/jof8010044","journal-title":"J Fungi (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1316_21","article-title":"Mucormycosis in COVID-19 patients","volume":"69","author":"Sundaram N","year":"2021","unstructured":"Sundaram N, Bhende T, Yashwant R, Jadhav S, Jain A. Mucormycosis in COVID-19 patients. Indian J Ophthalmol. 2021, 69:3728-33. 10.4103\/ijo.IJO_1316_21","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis WM","year":"1982","unstructured":"Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982, 31:1109-14. 10.2337\/diacare.31.12.1109","journal-title":"Diabetes"},{"key":"ref10","unstructured":"COVID-19-Associated Mucormycosis. Triple Threat of the Pandemic. (2021). Accessed: May 9, 2022: https:\/\/asm.org\/Articles\/2021\/July\/COVID-19-Associated-Mucormycosis-Triple-Threat-of."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7050a3","article-title":"Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021","volume":"70","author":"Dulski TM","year":"2021","unstructured":"Dulski TM, DeLong M, Garner K, et al.. Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:1750-1. 10.15585\/mmwr.mm7050a3","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/103206-a-rare-case-of-empyema-complicated-with-bronchopleural-fistula-secondary-to-mucormycosis-in-a-young-immunocompromised-diabetic-patient-with-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:02Z","timestamp":1707507602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/103206-a-rare-case-of-empyema-complicated-with-bronchopleural-fistula-secondary-to-mucormycosis-in-a-young-immunocompromised-diabetic-patient-with-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.26635","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}